IIT Guwahati collaborates with Hester Biosciences Limited to develop vaccine against COVID-19
The vaccine will be based on recombinant avian paramyxovirus based vector platform. The recombinant avian paramyxovirus-1 will be used to express the immunogenic protein of SARS-CoV-2.


































